Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5F6V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,113
Award facts
- Contract value 100% obligated
- $12,113.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,113.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 7.5 mg/0.5 mL pen auto-injectors on January 12, 2026, with completion targeted for January 13, 2026. This non-set-aside award was competitively procured and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
Zepbound is a GLP-1 receptor agonist approved by the FDA for chronic weight management and is being procured to support military healthcare system requirements. AmerisourceBergen, operating as a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across multiple therapeutic domains. The IDC vehicle under which this delivery order was issued encompasses an extensive variety of medical commodities including specialty medications, brand-name and generic drugs, vaccines, and other critical medical supplies required by military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26F5F6V?
SPE2DR26F5F6V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F5F6V worth?
The government has obligated $12,113 on SPE2DR26F5F6V.
Is contract SPE2DR26F5F6V an order under another contract?
Yes. SPE2DR26F5F6V is a delivery order under SPE2DR25D3306, an indefinite delivery contract.
Was contract SPE2DR26F5F6V competed?
The extent of competition for SPE2DR26F5F6V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award